BTX - Brooklyn ImmunoTherapuetics up 66% on no news or catalysts

Shares of Brooklyn ImmunoTherapeutics (BTX) have hit another 52-week high today and are up 66%, despite no catalysts, SEC filings, or news that might explain the run-up.At its highest today, shares traded at $44.48, ~79% above yesterday's closing price.Less than a week ago, the company recorded another 52-week high.In the last month alone, shares are up more than 423%.There is speculation that Brooklyn Immunotherapeutics is the target of a short squeeze play, given that that many users in the Wall Street Bets Reddit have discussed going after biotech stocks.The company was formed last month through a reverse merger with NTN Buzztime Inc.

For further details see:

Brooklyn ImmunoTherapuetics up 66% on no news or catalysts